Amended Canadian guidelines for prenatal diagnosis (2005) - Techniques for prenatal diagnosis;Lignes directrices canadiennes modifiées sur le diagnostic prénatal (2005)-Techniques de diagnostic prénatal

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 11, 2005, Pages 1055-1062

  Wilson, R D ^a   Davies, Greg ^b   Gagnon, Alain ^b   Desilets, Valerie ^b   Reid, Gregory J ^b   Summers, Anne ^b   Wyatt, Philip ^b   Allen, Victoria M ^c   Langlois, Sylvie ^b  

^a NONE   (United States)

^b NONE   (Canada)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADIAN; HUMAN; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS;

EID: 84971524484     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30507-2     Document Type: Article

References (70)

1. Krantz DA, Larsen JW, Buchanan PD, Macri JN First trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am J Obstet Gynecol 1996, 174:612-616.
2. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998, 352:343-346.
3. Wald NJ, Watt HC, Hackshaw AK Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 1999, 341:461-467.
4. Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW, Macri JN First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 2000, 96:207-213.
5. DeBiasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S First-trimester screening for Down syndrome using nuchal translucency measurements with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy-the combined test. Prenat Diagn 1999, 19:360-363.
6. Wapner R, Thorn E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N Eng J Med 349;15:1405-1413.
7. Malone FD, Wald NJ, Canick JA, Ball RH, Nyberg DA, Comstock CH, et al. First and second-trimester evaluation of risk (FASTER) trial: principal results of the NICHD multicentred Down syndrome screening study [abstract]. Am J Obstet Gynecol 189;6:S56.
8. Marthin T, Liedgren S, Hammar M Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand 1997, 76:728-732.
9. Tabor A, Bang J, Norgaard-Pedersen B Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987, 94:528-534.
10. Hess LW, Anderson RL, Golbus MS Significance of opaque discolored amniotic fluid at second trimester amniocentesis. Obstet Gynecol 1986, 67:44-46.
11. Fung Kee Fung K, Eason E, Crane J, Armson A, De La Ronde S, Farine D, et al. SOCG Clinical Practic Guidelines. Prevention of RH Alloimmunization. J Obstet Gynaecol Can 2003, 25(9):765-773.
12. Mid-trimester amniocentesis for prenatal diagnosis: safety and accuracy. J Am Med Assoc 1976, 236:1471-1476. National Institute of Child Health and Human Development, National Registry for Amniocentesis Study Group.
13. Diagnosis of genetic disease by amniocentesis during the second trimester of pregnancy 1977, Medical Research Council of Canada, Medical Research Council of Canada, Ottawa.
14. An assessment of the hazards of amniocentesis. Br J Obstet Gynaecol 1978, 85:1-4. Working Party on Amniocentesis.
15. Hunter AG, Thompson D, Speevak M Midtrimester genetic amniocentesis in eastern Ontario: a review from 1970 to 1985. J Med Genet 1987, 24:335-343.
16. Tabor A, Madsen M, Obel EB, Philip J, Bang J, Noergard-Peterson B Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986, 1(8493):1287-1293.
17. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First Report. Lancet 1989, 1(8628):1-6. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group.
18. Randomised trial to assess safety and fetal outcome of early and mid-trimester amniocentesis. Lancet 1998, 351:242-247. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group.
19. Eddleman K, Berkowitz R, Kharbutli Y, Malone F, Viddaver J, Flint Porter T, et al. Pregnancy loss rates after midtrimester amniocentesis: the FASTER trial. Am J Obstet Gynecol 2003, 189(6):S111.
20. D'Alton ME Prenatal diagnostic procedures. Semin Perinatol 1994, 18:140-162.
21. Romero R, Munoz H, Gomez R, et al. Two-thirds of spontaneous abortion/fetal deaths after genetic midtrimester amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity [abstract]. Am J Obstet Gynecol 1995, 172:261.
22. Wenstrom KD, Andrews WW, Tamura T, Du Bard MB, Johnston KE, Hemstreet GP Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 1996, 175:830-833.
23. Anandakumar C, Wong YC, Annapoorna V, Arulkumaran S, Chia D, Bongso A, et al. Amniocentesis and its complications. Aust N Z J Obstet JOGC Gynaecol 1992, 32:97-99.
24. Eller KM, Kuller JA Porencephaly secondary to fetal trauma during amniocentesis. Obstet Gynecol 1995, 85:865-867.
25. Petrikovsky BM, Kaplan GP Fetal responses to inadvertent contact with the needle during amniocentesis. Fetal Diagn Ther 1995, 10:83-85.
26. Wilson RD, Johnson J, Windrim R, Dansereau J, Singer J, Winsor EJT, et al. The early amniocentesis study: a randomized clinical trial of early amniocentesis and midtrimester amniocentesis. II. Evaluation of procedure details and neonatal congenital anomalies. Fetal Diagn Ther 1997, 12:97-101.
27. Sundberg K, Bang J, Smidt-Jensen S, Brocks V, Lundsteen C, Parner J, et al. Randomized study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997, 350(9079):697-703.
28. Anderson RL, Goldberg JD, Golbus MS Prenatal diagnosis in multiple gestation: 20 years' experience with amniocentesis. Prenat Diagn 1991, 11:263-270.
29. Taylor MJ, Fisk NM Prenatal cļiagnosis in multiple pregnancy. Bailliéres Clin Obstet Gynaecol 2000, 14:663-675.
30. Sebire NJ, Noble PL, Odibo A, Malligiannis P, Nicolaides KH Single uterine entry for genetic amniocentesis in twin pregnancies. Ultrasound Obstet Gynecol 1996, 7:26-31.
31. Bahado-Singh R, Schmitt R, Hobbins JC New technique for genetic amniocentesis in twins. Obstet Gynecol 1992, 79:304-307.
32. Buscaglia M, Chisoni L, Bellotti M, Marconi AM, Zamperini P, Stripparo L, et al. Genetic amniocentesis in biamnionic twin pregnancies by a single transabdominal insertion of the needle. Prenat Diagn 1995, 15:17-19.
33. Toth-Pal E, Papp C, Beke A, Ban Z, Papp Z Genetic amniocentesis in multiple pregnancy. Fetal Diagn Ther 2004, 19:138-144.
34. Pruggmayer M, Baumann P, Schutte H, Osmers R, Bartels I, Jovanovich V, et al. Incidence of abortion after genetic amniocentesis in twin pregnancies. Prenat Diagn 1991, 11:637-640.
35. Ghidini A, Lunch L, Hicks C, Alvarez M, Lockwood CJ The risk of second-trimester amniocentesis in twin gestations: a case-control study. Am J Obstet Gynecol 1993, 169:1013-1016.
36. Wilson RD, Kent NE, Johnson J, Bebbington M Twin gestation: evidence based outcome analysis and literature review for chromosomal aneurploidy, congenital malformations, and pregnancy loss. J Soc Obstet Gynecol Can 1997, 19:1189-1200.
37. Kohl S, Casey G Twin gestation. Mt Sinai J Med 1975, 42:523-539.
38. Coleman BG, Grumbach K, Arger PH, Mintz MC, Arenson RL, Mennuti M, et al. Twin gestations: monitoring of complications and anomalies with US. Radiology 1987, 165:449-453.
39. Pruggmayer M, Jahoda MG, Van de Pol JG, Baumann P, Holzgreve W, Karkut G, et al. Genetic amniocentesis in twin pregnancies: results of a multicenter study of 529 cases. Ultrasound Obstet Gynecol 1992, 2:6-10.
40. Winsor EJ, Tomkins DJ, Kalousek D, Farrell S, Wyatt P, Fan YS, et al. Cytogenetic aspects of the Canadian early and mid-trimester amniotic fluid trial (CEMAT). Prenat Diagn 1999, 19:620-627.
41. Philip J, Silver RK, Wilson RD, Thorn EA, Zachary JM, Mohide P, et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. The Am Coll Obstet Gynecol 103;6:1164-1173.
42. Wilson RD, Cho K, McGillivrary B, Kalousek D, Shaw D, Baldwin V Chorionic villus sampling; analysis of fetal losses to delivery, placental pathology and cervical microbiology. Prenat Diagn 1991, 11:539-550.
43. Brambati B, Lanzani A, Tului L Transabdominal and transcervical chorionic villus sampling: efficiency and risk evaluation of 2,411 cases. Am J Med Genet 1990, 35:160-164.
44. Shime J, Benzie R, Mohide P, Wilson D, Natale R, Johnson J Canadian multicenter randomized clinical trial of chorion villus sampling and amniocentesis: detailed obstetrical procedures and results. Prenat Diagn 1992, 12:411-422.
45. Wilson RD Chorionic villus sampling: a risk benefit breakdown. Can J Diagn 1996, 13(2):43-61.
46. Wapner RJ, Johnson A, Davis G, Urban A, Morgan P, Jackson L Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol 1993, 82:49-56.
47. De Catte L, Liebaers I, Foulon W, Bbnduelle M, Van Assche E First trimester chorionic villus sampling in twin gestations. Am J Perinatol 1996, 13:413-417.
48. Kalousek DK, Dill FJ, Pantzar T, McGillivray BC, Yong SL, Wilson RD Confined chorionic mosaicism in prenatal diagnosis. Hum Genet 1987, 77:163-167.
49. Kalousek DK, Howard-Peebles PN, Olson SB, Barrett IJ, Dorfmann A, Black SH, et al. Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat Diagn 1991, 11:743-750.
50. Kalousek DK, Langlois S, Barrett I, Yam I, Wilson DR, Howard-Peebles PN, et al. Uniparental disomy for chromosome 16 in humans. Am J Hum Genet 1993, 52:8-16.
51. Rudd N, Cox D Prenatal diagnosis: chorionic villus sampling (CVS) update. Bull Hared Dies Program Alberta 1989, 8:13-16.
52. Ledbetter DH, Martin AO, Verlinsky Y, Pergament E, Jackson L, Yang-Feng T, et al. Cytogenetic results of chorionic villus sampling: high success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol 1990, 162(2):495-501.
53. Wilson RD, Kendrick V, Wittmann BK, McGillivray B Spontaneous abortion and pregnancy outcome following normal first trimester ultrasound. Obstet Gynecol 1986, 67:352-355.
54. Rhoads GG, Jackson LG, Schlesselman SE, de la Cruz FF, Desnick RJ, Golbus MS, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Eng J Med 1989, 320:609-663.
55. MRC working party on the evaluation of chorion villus sampling. Lancet 1994, 337:1491-1499. Medical Research Council European trial of chorion villus sampling.
56. Silver RK, MacGregor SN, Muhlback LH, Kambich MP, Ragin A A comparison of pregnancy loss between transcervical and transabdominal chorionic villus sampling. Obstet Gynecol 1994, 83:657-660.
57. Chueh JT, Goldberg JD, Bohlferd MM, Golbus MS Comparison of transcervical and transabdominal chorionic villus sampling loss rates in nine thousand cases from a single center. Am J Obstet Gynecol 1995, 173:1277-1282.
58. Papp C, Beke A, Mezei G, Toth-Pal E, Papp Z Chorionic villus sampling: a 15-year experience. Fetal Diagn Ther 2002, 17:218-227.
59. Alfirevic Z, von Dadelszen P Instruments for chorionic villus sampling for prenatal diagnosis (Cochrane Review). In the Cochrane Library 2004, John Wiley & Sons, Ltd, Chichester, UK.
60. Alfirevic Z, Sundberg K, Brigham S Amniocentesis and chorionic villus sampling for prenatal diagnosis (Cochrane Review). In the Cochrane Library 2004, John Wiley & Sons, Ltd, Chichester, UK.
61. Borrell A, Fortuny A, Lazaro L, Costa D, Seres A, Pappa S, et al. First-trimester transcervical chorionic villus sampling by biopsy forceps versus midtrimester amniocentesis: a randomised controlled trial project. Prenat Diagn 1999, 19:1138-1142.
62. Froster-Iskenius UG, Baird PA Limb reduction defects in over one million consecutive live births. Teratology 1989, 39:127-135.
63. Firth HV, Boyd PA, Chamberlain P, MacKenzie IZ, Lindenbaum RH, Huson SM Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 1991, 337:762-763.
64. Burton BK, Schultz CJ, Burd LI Limb abnormalities associated with chorionic villus sampling. Obstet Gynecol 1992, 79:726-730.
65. Brambati B, Simoni G, Travi M, Danesino C, Tului L, Privitera O, et al. Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn 1992, 12(10):789-799.
66. Holmes LB Limb deficiency defects among 125,000 newborn infants. Am J Hum Genet 1992, 51:A18.
67. Stoll C, Alembik Y, Dott B, Roth MP Risk factors in limb reduction defects. Paediatr Perināt Epidemiol 1992, 6:323-338.
68. Froster UG, Jackson L Limb defects and chorionic villus sampling: results from an international registry, 1992-94. Lancet 1996, 347:489-494.
69. Evaluation of chorionic villus sampling safety. Prenat Diagn 1999, 19:97-99. WHO/PAHO Consultation on CVS.
70. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W Canadian Task Force on the Periodic Health Exam 1994, xxxvii. Canada Communication Group, Ottawa.